Skip to main content
All lobbying filings

SOCIETY FOR MATERNAL-FETAL MEDICINE

Lobbying for SOCIETY FOR MATERNAL-FETAL MEDICINE

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $10,000.00 expenses · posted Apr 22, 2026

Official filing document

 Lobbying activity 2
Budget/Appropriations

FY 2026 and FY 2027 funding for the National Institutes of Health, the Centers for Disease Control and Prevention, the Agency for Healthcare Research & Quality, and the Health Resources and Services Administration

Health Issues

inclusion of pregnant and lactating women in clinical trials, federal support for maternal mortality review committees and perinatal quality collaboratives

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem